A detailed history of Tower Research Capital LLC (Trc) transactions in Atri Cure, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 863 shares of ATRC stock, worth $26,511. This represents 0.0% of its overall portfolio holdings.

Number of Shares
863
Previous 8,871 90.27%
Holding current value
$26,511
Previous $201,000 88.06%
% of portfolio
0.0%
Previous 0.0%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$20.34 - $29.5 $162,882 - $236,236
-8,008 Reduced 90.27%
863 $24,000
Q2 2024

Aug 13, 2024

BUY
$19.86 - $29.09 $158,721 - $232,487
7,992 Added 909.22%
8,871 $201,000
Q1 2024

May 15, 2024

SELL
$28.21 - $37.78 $273,129 - $365,785
-9,682 Reduced 91.68%
879 $26,000
Q4 2023

Feb 13, 2024

BUY
$32.99 - $43.25 $257,091 - $337,047
7,793 Added 281.54%
10,561 $376,000
Q3 2023

Nov 14, 2023

SELL
$41.12 - $57.73 $11,266 - $15,818
-274 Reduced 9.01%
2,768 $121,000
Q2 2023

Aug 14, 2023

BUY
$40.44 - $49.6 $64,987 - $79,707
1,607 Added 111.99%
3,042 $150,000
Q1 2023

May 09, 2023

SELL
$35.87 - $47.22 $58,217 - $76,638
-1,623 Reduced 53.07%
1,435 $59,000
Q4 2022

Feb 10, 2023

SELL
$33.48 - $47.45 $58,924 - $83,512
-1,760 Reduced 36.53%
3,058 $136,000
Q3 2022

Nov 10, 2022

SELL
$38.25 - $52.62 $257,805 - $354,658
-6,740 Reduced 58.31%
4,818 $188,000
Q2 2022

Aug 15, 2022

BUY
$35.1 - $66.01 $381,888 - $718,188
10,880 Added 1604.72%
11,558 $472,000
Q1 2022

May 12, 2022

BUY
$57.43 - $71.39 $7,408 - $9,209
129 Added 23.5%
678 $45,000
Q4 2021

Feb 14, 2022

SELL
$63.4 - $87.14 $297,346 - $408,686
-4,690 Reduced 89.52%
549 $38,000
Q3 2021

Nov 15, 2021

BUY
$69.28 - $84.46 $209,572 - $255,491
3,025 Added 136.63%
5,239 $364,000
Q2 2021

Aug 16, 2021

SELL
$64.13 - $80.18 $75,994 - $95,013
-1,185 Reduced 34.86%
2,214 $176,000
Q1 2021

May 17, 2021

BUY
$53.79 - $66.98 $98,112 - $122,171
1,824 Added 115.81%
3,399 $223,000
Q4 2020

Feb 16, 2021

SELL
$34.56 - $57.55 $1.11 Million - $1.85 Million
-32,185 Reduced 95.33%
1,575 $88,000
Q3 2020

Nov 16, 2020

BUY
$38.36 - $46.91 $1.14 Million - $1.39 Million
29,658 Added 723.01%
33,760 $1.35 Million
Q2 2020

Aug 13, 2020

BUY
$31.78 - $51.19 $130,361 - $209,981
4,102 New
4,102 $184,000
Q1 2020

May 15, 2020

SELL
$24.49 - $43.84 $13,371 - $23,936
-546 Closed
0 $0
Q4 2019

Feb 07, 2020

BUY
$24.06 - $32.51 $9,551 - $12,906
397 Added 266.44%
546 $18,000
Q3 2019

Nov 05, 2019

SELL
$23.81 - $32.52 $13,190 - $18,016
-554 Reduced 78.81%
149 $4,000
Q2 2019

Aug 13, 2019

BUY
$26.85 - $30.74 $14,472 - $16,568
539 Added 328.66%
703 $21,000
Q1 2019

May 14, 2019

BUY
$26.38 - $33.34 $2,558 - $3,233
97 Added 144.78%
164 $4,000
Q4 2018

Feb 14, 2019

BUY
$26.66 - $34.85 $1,786 - $2,334
67 New
67 $2,000
Q4 2017

Feb 09, 2018

SELL
$17.69 - $23.44 $96,905 - $128,404
-5,478 Closed
0 $0
Q3 2017

Nov 14, 2017

BUY
$20.0 - $24.23 $109,560 - $132,731
5,478
5,478 $123,000

Others Institutions Holding ATRC

About AtriCure, Inc.


  • Ticker ATRC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 46,424,700
  • Market Cap $1.43B
  • Description
  • AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation...
More about ATRC
Track This Portfolio

Track Tower Research Capital LLC (Trc) Portfolio

Follow Tower Research Capital LLC (Trc) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.